Thai Interest Group for Endometriosis (TIGE) consensus statement on endometriosis-associated pain

Wisawasukmongchol, Wirach; Chalermchockcharoenkit, Amphan; Panyakhamlerd, Krasean; Ratchanon, Sarwinee; Luanratanakorn, Sanguanchoke; Sophonsritsuk, Areepan; Rungruxsirivorn, Tassawan; Choksuchat, Chainarong; Lertvikool, Srithean; Pantasri, Tawiwan

doi:10.1080/01443615.2022.2036965

Cited by 2 publications

(5 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…that could contribute to the development of endometriosis [ 51 ]. Nonetheless, there are emerging working groups in several Southeast Asia countries including Thailand and Malaysia, that are actively advocating early diagnosis of endometriosis, along with knowledge dissemination and support systems for endometriosis patients [ 52 , 53 ]. While improving general health and empowering the local community, these efforts collectively would allow researchers to understand the etiology of endometriosis before developing an effective management plan to tackle this multifactorial disease.…”

Section: How Common Is Endometriosis?mentioning

confidence: 99%

“…This may include surgical excision of lesions, non-drug therapies, analgesics, hormonal and non-hormonal therapies, or any of those approaches in combination [ 56 , 58 , 75 , 76 ]. Table 1 lists treatments for pain while Table 2 lists treatments for endometriosis-related infertility as per recommendations from international guidelines such as the ESHRE Guideline and National Institute for Health and Care Excellence (NICE) Guideline, along with the national consensus or guidelines such as the Thailand Interest Group for Endometriosis (TIGE), the Obstetrical and Gynecological Society of Malaysia (OGSM), the American Society of Reproductive Medicine (ASRM) [ 52 , 56 , 57 , 77 , 78 ]. Researchers highlighted the lack of reliable information regarding the effects of laparoscopic surgery for the contravention of the recommendations, which has led to many doubts and uncertainties in providing patients with a better quality of life and, most importantly, minimizing pain [ 79 ].…”

Section: Diagnosis and Management Of Endometriosismentioning

confidence: 99%

See 1 more Smart Citation

Current Updates on the Role of Microbiome in Endometriosis: A Narrative Review

et al. 2023

View full text Add to dashboard Cite

Endometriosis affects approximately 6 to 10% of reproductive-age women globally. Despite much effort invested, the pathogenesis that promotes the development, as well as the progression of this chronic inflammatory disease, is poorly understood. The imbalance in the microbiome or dysbiosis has been implicated in a variety of human diseases, especially the gut microbiome. In the case of endometriosis, emerging evidence suggests that there may be urogenital-gastrointestinal crosstalk that leads to the development of endometriosis. Researchers may now exploit important information from microbiome studies to design endometriosis treatment strategies and disease biomarkers with the use of advanced molecular technologies and increased computational capacity. Future studies into the functional profile of the microbiome would greatly assist in the development of microbiome-based therapies to alleviate endometriosis symptoms and improve the quality of life of women suffering from endometriosis.

show abstract

Section: How Common Is Endometriosis?mentioning

confidence: 99%

Section: Diagnosis and Management Of Endometriosismentioning

confidence: 99%

Current Updates on the Role of Microbiome in Endometriosis: A Narrative Review

et al. 2023

View full text Add to dashboard Cite

show abstract

“…Around the world, substantial delays of between 3 and 12 years between symptom onset and diagnosis have been documented, with most publications reporting delays of 6–8 years 5,21,33–40 . This represents a significant challenge that can result in years of suboptimal treatment and potential disease progression 5 .…”

Section: Introductionmentioning

confidence: 99%

“…13 Around the world, substantial delays of between 3 and 12 years between symptom onset and diagnosis have been documented, with most publications reporting delays of 6-8 years. 5,21,[33][34][35][36][37][38][39][40] This represents a significant challenge that can result in years of suboptimal treatment and potential disease progression. 5 As with epidemiological data, there are challenges in accurately estimating diagnostic delays, as estimates may be skewed due to recall bias and the fact that women are more likely to report if they have had negative experiences with delays.…”

Section: Introductionmentioning

confidence: 99%

“…The Asian Society of Endometriosis & Adenomyosis (ASEA) reports a prevalence of approximately 10% in Asian women of reproductive age, 15 a percentage that is generally accepted in the Asian region due to a scarcity of robust and up‐to‐date country‐specific data. Available prevalence data from individual Asian countries range from 7% in Japan (self‐reported by nurses), 20 9% in Thailand, 21 ~10% in India, 22–24 12% in Taiwan, 17 to as high as 15%–20% in Singapore 25 . In Asia‐Pacific (APAC) countries with a lower predominance of Asian ethnicities, the prevalence is slightly lower as expected.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Improving the diagnosis of endometriosis in Asia‐Pacific: Consensus from the Asia‐Pacific Endometriosis Expert Panel for Endometriosis

Yen,

Hamdan,

Hengrasmee

et al. 2023

Intl J Gynecology & Obste

Self Cite

View full text Add to dashboard Cite

Endometriosis should be diagnosed as early as possible in the continuum of care; but substantial delays of approximately 6–8 years between symptom onset and endometriosis diagnosis have been widely reported. With the purpose of improving the prompt diagnosis of endometriosis, the Asia‐Pacific Endometriosis Expert Panel (APEX) sought to address the reasons for diagnostic delays across the region, and formulate a multi‐pronged approach to overcoming these challenges. In the first instance, clinical diagnosis is preferable to surgical diagnosis, in order to facilitate earlier empirical treatment and minimize the negative sequelae of undiagnosed/untreated disease. There should be a high clinical index of suspicion in women presenting with cyclical symptoms, including those involving extrapelvic organs. Diagnostic delays in Asia‐Pacific countries are attributable to a variety of patient, physician, and healthcare factors, including poor awareness, normalization/trivialization of pain, individual/cultural attitudes toward menstruation, default use of symptom‐suppressing treatments, misdiagnosis, and a lack of diagnostic resourcing or adequate referral pathways in some areas. Suggested initiatives to reduce diagnostic delays are geared toward improving public awareness, improving clinical diagnostic skills, streamlining multidisciplinary care pathways for timely referral, updating and implementing diagnostic guidelines, lobbying policymakers and insurance companies for endometriosis support, and increasing efforts to bridge data gaps and perform further research in this field. Formulating specific action plans and gathering traction are the responsibility of individual countries within local parameters. The APEX group advocates for any initiatives and policies that support the unmet needs of women with endometriosis, to improve patient experience and outcomes.

show abstract

Thai Interest Group for Endometriosis (TIGE) consensus statement on endometriosis-associated pain

Cited by 2 publications

References 41 publications

Current Updates on the Role of Microbiome in Endometriosis: A Narrative Review

Current Updates on the Role of Microbiome in Endometriosis: A Narrative Review

Improving the diagnosis of endometriosis in Asia‐Pacific: Consensus from the Asia‐Pacific Endometriosis Expert Panel for Endometriosis

Contact Info

Product

Resources

About